A
Arduino A. Mangoni
Researcher at Flinders Medical Centre
Publications - 397
Citations - 10350
Arduino A. Mangoni is an academic researcher from Flinders Medical Centre. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 42, co-authored 348 publications receiving 7835 citations. Previous affiliations of Arduino A. Mangoni include University of Cambridge & King's College London.
Papers
More filters
Journal ArticleDOI
Reproducibility of ultrasound assessment of common carotid and femoral artery compliance and distensibility in the anesthetized rat
Luca Mircoli,Arduino A. Mangoni,Stefano Perlini,Cristina Giannattasio,Alberto U. Ferrari,Giuseppe Mancia +5 more
TL;DR: In the anesthetized rat, ultrasound evaluation of the mechanical properties of the common carotid and femoral arteries is a reliable and reproducible technique.
Journal ArticleDOI
Blood Cell Count Indexes of Systemic Inflammation in Carotid Artery Disease: Current Evidence and Future Perspectives
Paola Dettori,Panagiotis Paliogiannis,Rosa Maria Pascale,Angelo Zinellu,Arduino A. Mangoni,Gianfranco Pintus +5 more
TL;DR: In this paper, the authors discuss the available evidence regarding the role of common blood cell count (BCC) indexes in the diagnosis and risk stratification of carotid artery disease, and their potential clinical applications.
Journal ArticleDOI
Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?
Gian Luca Erre,Edoardo Sean Ferraccioli,Matteo Piga,Arduino A. Mangoni,Giuseppe Passiu,Elisa Gremese,Gianfranco Ferraccioli +6 more
TL;DR: Low-dose antimalarials are the mainstay to control immunological response and to prevent flare in patients with rheumatic disease, primarily affecting patients with systemic lupus erythematosus and rheumatoid arthritis.
Journal ArticleDOI
Methotrexate and Vasculoprotection: Mechanistic Insights and Potential Therapeutic Applications in Old Age.
Arduino A. Mangoni,Sara Tommasi,Angelo Zinellu,Salvatore Sotgia,Stefania Bassu,Matteo Piga,Gian L. Erre,Ciriaco Carru +7 more
TL;DR: Methotrexate has the potential to be repurposed for cardiovascular risk management in old age in view of its putative pharmacological effects on inflammation, vascular homeostasis, and blood pressure.